84 related articles for article (PubMed ID: 26402882)
1. Non-albumininuric proteinuria: a urinary tubular marker in the diagnosis of diabetic kidney disease.
De Carvalho JA; Tatsch E; Hausen BS; Londero SW; Comim FV; Moresco RN
Clin Chem Lab Med; 2016 Mar; 54(3):e85-8. PubMed ID: 26402882
[No Abstract] [Full Text] [Related]
2. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
[TBL] [Abstract][Full Text] [Related]
3. Novel urinary biomarkers in early diabetic kidney disease.
Kamijo-Ikemori A; Sugaya T; Kimura K
Curr Diab Rep; 2014 Aug; 14(8):513. PubMed ID: 24919751
[TBL] [Abstract][Full Text] [Related]
4. Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients.
Nielsen SE; Reinhard H; Zdunek D; Hess G; Gutiérrez OM; Wolf M; Parving HH; Jacobsen PK; Rossing P
Diabetes Res Clin Pract; 2012 Jul; 97(1):71-6. PubMed ID: 22402306
[TBL] [Abstract][Full Text] [Related]
5. Comparison of intrarenal renin-angiotensin system activity in diabetic versus non-diabetic patients with overt proteinuria.
Park JH; Jang HR; Lee JH; Lee JE; Huh W; Lee KB; Kwon YJ; Do JY; Kim HY; Kim YG
Nephrology (Carlton); 2015 Apr; 20(4):279-85. PubMed ID: 25522682
[TBL] [Abstract][Full Text] [Related]
6. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes.
de Carvalho JA; Tatsch E; Hausen BS; Bollick YS; Moretto MB; Duarte T; Duarte MM; Londero SW; Premaor MO; Comim FV; Delanghe JR; Moresco RN
Clin Biochem; 2016 Feb; 49(3):232-6. PubMed ID: 26519090
[TBL] [Abstract][Full Text] [Related]
7. Urinary gamma-glutamyl transferase (GGT) as a marker of tubular proteinuria in dogs with canine leishmaniasis, using sodium dodecylsulphate (SDS) electrophoresis as a reference method.
Ibba F; Mangiagalli G; Paltrinieri S
Vet J; 2016 Apr; 210():89-91. PubMed ID: 26897435
[TBL] [Abstract][Full Text] [Related]
8. [Protein markers of diabetic nephropathy during a functional exercise test].
Rakov SS; Basharova NG; Balabolkin MI
Klin Lab Diagn; 1994; (2):24-5. PubMed ID: 8032749
[No Abstract] [Full Text] [Related]
9. Diagnostic strategy to monitor diabetic nephropathy.
Rowe DJ; Twyman S
Kidney Int Suppl; 1994 Nov; 47():S109-10. PubMed ID: 7869658
[TBL] [Abstract][Full Text] [Related]
10. Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine.
Gronwald W; Klein MS; Zeltner R; Schulze BD; Reinhold SW; Deutschmann M; Immervoll AK; Böger CA; Banas B; Eckardt KU; Oefner PJ
Kidney Int; 2011 Jun; 79(11):1244-53. PubMed ID: 21389975
[TBL] [Abstract][Full Text] [Related]
11. "Normoalbuminuric" diabetic nephropathy: tubular damage and NGAL.
Lacquaniti A; Donato V; Pintaudi B; Di Vieste G; Chirico V; Buemi A; Di Benedetto A; Arena A; Buemi M
Acta Diabetol; 2013 Dec; 50(6):935-42. PubMed ID: 23754672
[TBL] [Abstract][Full Text] [Related]
12. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK
Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044
[TBL] [Abstract][Full Text] [Related]
13. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy.
Ding H; He Y; Li K; Yang J; Li X; Lu R; Gao W
Clin Immunol; 2007 May; 123(2):227-34. PubMed ID: 17360238
[TBL] [Abstract][Full Text] [Related]
14. Urinary type IV collagen excretion predicts subsequent declining renal function in type 2 diabetic patients with proteinuria.
Katavetin P; Katavetin P; Susantitaphong P; Townamchai N; Tiranathanagul K; Tungsanga K; Eiam-Ong S
Diabetes Res Clin Pract; 2010 Aug; 89(2):e33-5. PubMed ID: 20542586
[TBL] [Abstract][Full Text] [Related]
15. Tubulopathy with macroalbuminuria due to diabetic nephropathy and primary glomerulonephritis.
Yaqoob M; McClelland P; Patrick AW; Stevenson A; Mason H; Bell GM
Kidney Int Suppl; 1994 Nov; 47():S101-4. PubMed ID: 7869656
[TBL] [Abstract][Full Text] [Related]
16. [Characteristics of the proteinuria in diabetic nephropathy].
Astrug A; Genov D
Vutr Boles; 1978; 17(2):72-9. PubMed ID: 77585
[TBL] [Abstract][Full Text] [Related]
17. Tubular proteinuria in diabetic children. A 3-year follow-up study.
Ginevri F; Picotti E; Alinovi R; DeToni T; Bocchi CM; Mazzarello I; Perfumo F; Ghiggeri GM; Gusmano R
Contrib Nephrol; 1993; 101():121-6. PubMed ID: 8467664
[No Abstract] [Full Text] [Related]
18. Investigation of apparent non-albuminuric proteinuria in a primary care population.
McTaggart MP; Stevens PE; Price CP; Newall RG; Pinnock RG; Lamb EJ
Clin Chem Lab Med; 2013 Oct; 51(10):1961-9. PubMed ID: 23729629
[TBL] [Abstract][Full Text] [Related]
19. The pre-proteinuric phase of diabetic nephropathy.
Christensen CK
Dan Med Bull; 1991 Apr; 38(2):145-59. PubMed ID: 2060322
[No Abstract] [Full Text] [Related]
20. Proteomic approaches for discovering biomarkers of diabetic nephropathy.
Ben Ameur R; Molina L; Bolvin C; Kifagi C; Jarraya F; Ayadi H; Molina F; Granier C
Nephrol Dial Transplant; 2010 Sep; 25(9):2866-75. PubMed ID: 20472580
[No Abstract] [Full Text] [Related]
[Next] [New Search]
